Proactive - Interviews for investors

Riversgold Ltd (ASX:RGL) chairman David Lenigas sits down with Proactive’s Jonathan Jackson to discuss excellent results stemming from a site visit to sample multiple prospects at its Tambourah Project. David, good to see you.

During the visit Riversgold sampled multiple prospects at Tambourah, located 160 kilometres southeast of Port Hedland in Western Australia. The visit returned exceptional rock chip results, including 101 g/t gold and 21.78% copper. These findings validated historical exploration results and confirmed an anomalous copper and gold trend over a 12-kilometre strike length.

Significant results included a rock chip from the Lone Star prospect with 101 g/t gold and 4.1% copper, and samples from the Hawkstone prospect yielded 21.78% copper and 3.3 g/t gold, and 16.78% copper and 2.4 g/t gold. Additionally, the Logans Find prospect registered up to 67.1 g/t gold. This news increased RGL's share price by up to 33.33% to 0.008 during morning trade.

Lenigas described the results as a tremendously exciting development, highlighting the potential for further exploration driven by these surface findings. The company is focusing on the copper and gold potential at Tambourah as part of its broader exploration strategy.

Technical director Ed Mead, who sampled the areas during the site visit, identified several gabbro intrusions that could be the source of the mineralisation. Riversgold plans to continue exploration in the coming weeks.

Riversgold targeted five prospects for copper and gold at Tambourah -Logans Find, Lone Star, Hawkstone, Shaw Mullock and Trafalgar. The company is updating its regional geological modelling to revise the exploration strategy for the entire Tambourah Project.

#ProactiveInvestors #Riversgold #ASX #TambourahProject #GoldMining #CopperMining #Exploration #WesternAustralia #MiningNews #Gold #Copper #StockMarket #Investing #Geology #RockChipResults #MiningIndustry #DavidLenigas #EdMead #Mineralisation #GabbroIntrusions #HistoricalExploration #GeologicalModelling

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Iondrive Ltd (ASX:ION) has initiated a Benchmarking Study with the Production Engineering of E-Mobility Components (PEM) department at RWTH Aachen University, recognised for its expertise in automotive battery technology and recycling.

PEM is noted for its successful partnerships, including one with Henkel, which focus on next-generation battery technologies and improving battery safety and sustainability. This study will evaluate the economics of Iondrive’s battery recycling technology for a 10,000 tonnes per annum black mass operation in Europe compared to traditional hydrometallurgical processes.

Simultaneously, Iondrive has commenced an Engineering Study with Koch Modular Process Systems, a global leader in process engineering and modular construction. Koch Modular provides early-stage technology companies with vital data and insights to enhance commercialisation viability. Their advancements in metals recovery and purification offer the battery recycling industry efficient, cost-effective solutions. This study will review laboratory testing and each step of the process, including solvent recovery and the use of deep eutectic solvents (DES), to develop an economical, commercial-scale process.

Both studies are integral to Iondrive’s pre-feasibility study (PFS), scheduled for completion by October 2024. These efforts aim to optimise Iondrive’s environmentally sustainable battery recycling process for commercial scalability and economic viability.

#ProactiveInvestors #Iondrive #ASX #BatteryRecycling, #EMobility, #Sustainability, #RWTHAachen, #KochModular, #EngineeringStudy, #Benchmarking, #Technology, #Innovation, #BatteryTechnology, #Automotive, #Hydrometallurgical, #DES, #Commercialisation, #MetalsRecovery, #Economics, #PreFeasibilityStudy, #CommercialScalability, #Investment

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Far East Gold Ltd (ASX:FEG) CEO Shane Menere joins Jonathan Jackson in the Proactive studio to discuss a Binding Term Sheet (BTS) with PT Iriana Mutiara Idenburg (IMI) to acquire up to 100% of the Idenburg Gold Project in Papua, Indonesia.

The 95,280-hectare Contract of Work (CoW) is in a region known for significant gold and copper deposits, such as Grasberg and Porgera. Historical exploration worth more than US$25 million, including 5,531 metres of diamond drilling, indicates the project's advanced status. The deposit is orogenic, akin to notable goldfields like Kalgoorlie and South Eastern Australia.

Noteworthy is that major gold producers, including Barrick, Newmont and Newcrest, have previously explored the site. Despite extensive exploration, only 30% of the CoW has been detailed and metallurgical testing shows promising gold recoverability. An independent report by SMGC suggests an exploration target of up to 7.2 million ounces at 6.1 g/t gold, though this remains conceptual.

The project benefits from excellent logistics, being just 120 kilometres south of Jayapura and intersected by the Trans Papua Highway. The deal terms include staged earn-in and minimal cash payments. FEG's acquisition is facilitated by the removal of previous forestry restrictions that hindered development. The company sees this as an endorsement of its exploration capabilities and looks forward to further developing the Idenburg project.

The company has also appointed non-executive chair Justin Werner with immediate effect.

#ProctiveInvestors #FarEastGold #ASX #IdenburgProject, #GoldMining, #PapuaIndonesia, #MiningAcquisition, #GoldExploration, #ContractOfWork, #GoldDeposit, #MetallurgicalTesting, #OrogenicGold, #MiningDeal, #ExplorationTargets, #SMGCReport, #BarrickGold, #Newmont, #Newcrest, #TransPapuaHighway, #HistoricalExploration, #GoldRecovery, #MiningDevelopment

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

First Phosphate Corp Chief Geologist Gilles Laverdiere joined Steve Darling from Proactive to discuss the latest results from the company's Bégin-Lamarche project in Quebec. The company has completed a 25,929-meter drill program ahead of schedule in April, with all samples now shipped to the lab for analysis. A 43-101 resource estimate will soon be initiated, followed by a Preliminary Economic Assessment. Both studies are expected to be completed by the end of fiscal Q4 2024.

Laverdiere highlighted that significant phosphate layers were intersected in all but two holes continuously across the 3 km magnetic trend at Bégin-Lamarche. A total of 23 drill holes have been completed in the Phosphate Mountain Zone, with data from 20 drill holes showing grades over 10% P2O5, with widths ranging from 7 m to 99 m. The Phosphate Mountain Zone has been drilled for a total length of 250 m so far and is beginning to merge with the Northern Zone, where a 500 m thick phosphate mineralized envelope exists. This envelope has delineated up to five individual layers ranging from 60 m to 100 m in thickness, starting at the surface and continuing down to a depth of 300 m. The overall strike length of the Phosphate Mountain Zone and the Northern Zone is approximately 600 meters.

Laverdiere expressed optimism about these results, emphasizing that they showcase the robust potential of the Bégin-Lamarche project. With the upcoming resource estimate and economic assessment, First Phosphate Corp aims to solidify its position as a key player in the phosphate mining sector

#proactiveinvestors #firstphosphatecorp #phosphate #BéginLamarcheproject #CEOInterview #CompanyUpdate #StrategicGrowth #SustainableMining #GreenApproach

#Geology, #Mining, #PhosphateDrilling, #ResourceEstimate, #PEA, #MountainZone, #NorthZone, #SouthZone, #DrillProgramme, #MineralExploration, #HighGradePhosphate, #GeologicalSurvey, #MiningConsultants, #3DModel, #EconomicAssessment, #ProactiveNews, #GeologicalResources, #MineralDeposit, #MiningIndustry#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

DJ Seeterlin, Chief Innovation and Strategy Officer, and Kevin Wood, Managing Director of Flexent at Chesapeake Bank, recently joined Steve Darling from Proactive to discuss an exciting new business initiative in the trucking sector. Chesapeake Bank, known for offering the Flexent program focusing on accounts receivable financing since 1995, has taken a significant step forward to address a pressing need in the industry.

In 2023, recognizing the necessity for faster payment solutions for truck drivers—who often need immediate funds for expenses such as fuel and repairs—Chesapeake Bank acquired another company to develop a real-time payments system. This innovative system allows truck drivers to receive funds instantly upon load delivery and paperwork submission, effectively bypassing slower methods like ACH and expensive wire transfers. The initiative has already seen strong adoption, with 93% of truck drivers preferring instant payments.

Chesapeake Bank has been a pioneer in adopting real-time payment technologies, being among the first 25 banks in the US to implement them in 2020. Their early involvement and proactive approach in the industry have enabled them to swiftly deploy these solutions, demonstrating their commitment to innovation and customer satisfaction.

The new service is expected to significantly benefit the trucking sector by providing faster and more efficient payment options. Additionally, it is poised to enhance Chesapeake Bank's traditional receivables financing business, while also generating additional revenue through ancillary products. This initiative underscores Chesapeake Bank's dedication to meeting the evolving needs of its clients and advancing the financial services industry.

The company emphasized the importance of this development, highlighting how the real-time payments system not only supports truck drivers in their day-to-day operations but also strengthens Chesapeake Bank's position as a leader in financial innovation. As the trucking industry continues to grow and evolve, Chesapeake Bank remains committed to providing cutting-edge solutions that drive success for their clients.

#proactiveinvestors #chesapeakefianancialsharesinc #otcqx #ckpf

#TruckingIndustry, #RealTimePayments, #AccountsReceivableFinancing, #InnovationInBanking, #FinancialServices, #TruckDrivers, #InstantPayments, #PaymentSolutions, #BusinessFinancing, #Fintech, #RevenueGrowth, #CustomerService, #FinancialInnovation, #BankingSolutions, #FuelExpenses, #TruckRepairs, #USBanking, #PaymentTechnologies

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

In the latest edition of Proactive's Crypto Report, Stephen Gunnion interviews Billy Farrington about the current state of the Bitcoin market.

Farrington noted an increase in volatility over the past week, with daily fluctuations of up to 5%. He attributes this to decreased trading volumes following Bitcoin's recent halving event. Despite positive US inflation data, which showed a drop to 3% year-on-year in June, Bitcoin did not experience the expected price increase. Currently, Bitcoin's price has slightly increased week-on-week but remains 15% down against the US dollar.

The upcoming Bitcoin 2024 conference will feature a diverse lineup of speakers, including Donald Trump, Russell Brand, Edward Snowden, Cathie Wood, and Michael Saylor. Farrington mentioned Trump's historically sceptical stance on Bitcoin, though recent Republican policies have shown more support for cryptocurrency.

The Republican National Committee's platform opposes a central bank digital currency and supports the right to mine and self-custody Bitcoin. This shift is seen as a strategic political move contrasting with the Democrats' more cautious approach to cryptocurrency.

Farrington concluded by noting the interesting mix of speakers and the potential impact of their discussions at the conference.

#Proactive, #CryptoReport, #Bitcoin, #Cryptocurrency, #Volatility, #TradingVolume, #USInflation, #Bitcoin2024, #DonaldTrump, #RussellBrand, #EdwardSnowden, #CathieWood, #MichaelSaylor, #CryptoConference, #MarketTrends, #CryptoNews, #RepublicanCryptoPolicy, #BitcoinHalving, #FinancialNews, #CryptoMarket #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Lunnon Metals Ltd (ASX:LM8, OTC:LNMLF) managing director and CEO Edmund Ainscough spoke with Proactive's Stephen Gunnion about BHP's decision to suspend its Nickel West operations in Australia until at least 2027 and its impact on Lunnon Metals.

Ainscough explained the decision brings clarity to the market. He said BHP had already announced the closure of the Kambalda Nickel Concentrator in February, highlighting that this event allows Lunnon Metals to move forward without the constraints of relying on BHP's infrastructure. "It's time to look forward to a future that doesn't necessarily involve that Kambalda concentrator or BHP," Ainscough stated.

Lunnon Metals has been preparing for this shift, having already identified a site on its tenements for a new, modern float plant. This site, previously home to the St Ives gold plant, offers existing infrastructure that will facilitate the development of their own concentrator. Ainscough noted the resilience and profitability of its nickel assets, stating it is well-positioned to finance the new concentrator independently.

When asked about the impact on the Foster South nickel project, Ainscough confirmed that their focus remains on gold to generate immediate revenue, despite the positive news for nickel. He also discussed the recent seismic survey data from the Long South Gap exploration program, indicating potential new nickel channels that could be explored when market conditions improve.

For more insights from industry leaders and updates on key projects, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to our channel, and enable notifications for future content.

#LunnonMetals #NickelWest #BHP #NickelMining #MiningNews #EdmundAinscough #GoldExploration #MiningIndustry #ProactiveInvestors #SeismicSurvey #NickelAssets

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Digbee Limited founder and CEO Jamie Strauss and Marimaca Copper Corp's José Antonio Merino joined Proactive's Stephen Gunnion with details of the third Digbee assessment of the Marimaca Copper Project in Chile's Antofagasta region.

Merino discussed the strategic impact of the assessment, highlighting the company's commitment to high ESG standards. "We are on track to achieve our goals based on the project's features and specific actions we are taking," Merino said.

The project benefits from its location, offering reduced environmental sensitivities and access to seawater, contributing to a low carbon footprint. The Digbee assessment has provided material validation of Marimaca's ESG goals, enhancing engagement with stakeholders and authorities.

Looking ahead, Merino outlined the company's goals for the next 12 months, including submitting its environmental application and delivering a definitive feasibility study (DFS). Significant progress is expected in project financing and community engagement, with ongoing efforts to present the project to the local community.

Strauss emphasised the importance of sustainability in the mining industry and how Digbee's assessments help companies like Marimaca connect with younger generations and build trust within the industry.

Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content.

#MarimacaCopper #DigbeeAssessment #ESGStandards #Sustainability #MiningIndustry #StakeholderEngagement #ProactiveInvestors #JamieStrauss #JoséAntonioMerino #CopperMining #EnvironmentalGoals #ProjectDevelopment#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Lisata Therapeutics Inc chief medical officer Kristen Buck joined Proactive's Stephen Gunnion to discuss encouraging preclinical results for drug candidate certepetide in treating intrahepatic cholangiocarcinoma (bile duct cancer).

Buck explained that the study involved a mouse model with orthotopically implanted cholangiocarcinoma, separated into four treatment groups: a control group, a group receiving only certepetide, a group treated with gemcitabine, cisplatin, and anti-PD-1 immunotherapy, and a group receiving certepetide in combination with the chemotherapy and immunotherapy. The results demonstrated that certepetide significantly enhanced the effects of chemotherapy and immunotherapy, prolonging survival, reducing lung metastases, and decreasing comorbidities like ascites.

Buck highlighted that certepetide targets two specific receptors upregulated on solid tumors and helps transform the fibrotic stromal barrier in cholangiocarcinoma into a conduit for chemotherapy and immunotherapy, improving drug penetration into the tumor. These promising preclinical results come on top of the ongoing BOLSTER trial, a Phase 2a study evaluating certepetide in humans with first-line cholangiocarcinoma and a secondary cohort for second-line treatment.

"We believe that using our drug in combination with immunotherapy will demonstrate a significant benefit," says Buck. "Certepetide not only targets and penetrates tumors but also modifies the hostile tumor microenvironment, decreasing T regulatory cells and increasing cytotoxic T-cells to help kill cancer."

For more insightful videos like this, visit Proactive's YouTube channel. Don't forget to give the video a like, subscribe to our channel, and enable notifications for future content.

#LisataTherapeutics #CancerResearch #Certepetide #Cholangiocarcinoma #CancerTreatment #Immunotherapy #PreclinicalResults #Oncology #MedicalResearch #ProactiveInterviews

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Faron Pharmaceuticals Limited (AIM:FARN) CEO Dr Juho Jalkanen joined Proactive's Stephen Gunnion with details of the positive feedback from the US Food and Drug Administration (FDA) regarding its Phase III clinical trial for its lead asset, bexmarilimab (BEXMAB).

Jalkanen shared that the FDA’s guidance will accelerate trials, potentially bringing new treatments to the market sooner.

He explained, “We went with a humble attitude to the FDA, proposing a Phase III trial for relapsed refractory MDS. The big news is that the FDA recommended going directly into a frontline MDS study, opening up a much larger market sooner than anticipated.”

This acceleration not only speeds up the process but also targets a larger patient population without significantly increasing trial costs.

Jalkanen also highlighted the importance of the Frontrunner program, which promises to bring treatments to patients faster in areas of high unmet need. The feedback from the FDA will significantly impact their commercial forecasts and development plans for BEXMAB.

Faron Pharmaceuticals will continue with Phase II trials as planned, aiming to use the results for potential approval in relapsed refractory populations while preparing for Phase III trials in the frontline population next year.

Stay updated with more insights from Faron Pharmaceuticals by visiting Proactive's YouTube channel. Don't forget to like, subscribe, and enable notifications for future content.

#FaronPharmaceuticals #BEXMAB #FDAApproval #ClinicalTrials #MDSTreatment #BiotechNews #ProactiveInterviews #DrJuhoJalkanen #Pharmaceuticals #MedicalResearch

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews